Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation.

Cancer Med · 2017 · PMC5345676 · PMID 28135039

Europe PMC DOI

hedged sentence

0.5610

closest p · 11.2× alpha

0.5610

boldest claim

The sentences

did not reach statistical significanceP = 0.561not close (p > 0.1)

Compared to patients with non‐V600E mutations, patients with V600E‐mutated tumors had a shorter PFS to first‐line chemotherapy, although this did not reach statistical significance (5.2 vs. 6.4 months; P = 0.561).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.